Carolyn Moloney
Overview
Explore the profile of Carolyn Moloney including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demir T, Moloney C, Mahalingam D
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075563
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with a poor prognosis. Currently, chemotherapy is the only option for most patients with advanced-stage PDAC. Further, conventional immunotherapies and targeted therapies...
2.
Demir T, Araz M, Moloney C, Hendem E, Kocak M, Erman M, et al.
Clin Lung Cancer
. 2024 Jun;
25(7):e316-e322.
PMID: 38871540
Background: Invasive mucinous adenocarcinoma (IMA) is a rare histological subtype of lung invasive adenocarcinoma with unique clinical, radiological, histopathological, and genomic characteristics. There have been limited studies on the effectiveness...
3.
Demir T, Moloney C, Mahalingam D
Crit Rev Oncol Hematol
. 2024 May;
199:104388.
PMID: 38754771
In the last decade, targeted therapies have shown rapid advancement in biliary tract cancer (BTC). Today, many targeted agents are available and under investigation for patients with BTC. More recently,...
4.
Kieran R, Mitchell T, Fazari A, Chinoy A, Moloney C, McCaffrey J
J Oncol Pharm Pract
. 2023 Aug;
30(6):977-982.
PMID: 37559385
Introduction: Fluorouracil (5FU) and capecitabine are metabolised by dihydropyrimidine dehydrogenase (DPD). Up to 9% of people have low levels of a working DPD enzyme and are at risk of severe...
5.
Kieran R, Moloney C, Alken S, Corrigan L, Gallagher D, Grant C, et al.
Ir J Med Sci
. 2022 Apr;
192(2):533-540.
PMID: 35411487
Background: Oncology patients have had to make many changes to minimise their exposure to COVID-19, causing stress. Despite education, some patients still do not recognise potential COVID symptoms. Aims: We...
6.
Moloney C, Shiely F
J Clin Epidemiol
. 2022 Mar;
147:132-141.
PMID: 35341945
Objectives: Under-served groups are populations unrepresented or disengaged from medical research or services despite a disproportionately high healthcare burden. Under-served groups may be directly (age, pregnancy as examples) or indirectly...
7.
Moloney C, Allen M, Power D, Bambury R, OMahony D, ODonnell D, et al.
Oncologist
. 2020 Nov;
26(4):e603-e607.
PMID: 33252154
Introduction: "Transgender" and "gender diverse" are umbrella terms encompassing those whose gender identities or expressions differ from those typically associated with the sex they were assigned at birth. There is...